newsfilter
← Latest News
Business Wire·

QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million

QGEN
  • QIAGEN plans to return approximately $500 million to shareholders via a synthetic share repurchase to be completed on January 7, 2026.
  • The transaction combines a direct capital repayment of $2.29 per pre-consolidation share with a reverse stock split.
  • This return brings total shareholder distributions to about $1.15 billion since early 2024, exceeding the $1 billion commitment by end-2028 well ahead of schedule.
  • The reverse split consolidates every 20 issued shares into 19, reducing the total share count by approximately 10.9 million shares from the December 18, 2025 level.
  • Shareholders will see an estimated 5% reduction in issued shares based on current pricing, enhancing earnings per share (EPS).
  • The last trading day for pre-split shares is January 7, 2026, with consolidated shares expected to trade on January 8, 2026, under existing tickers QGEN (NYSE) & QIA (Frankfurt).
  • New security identifiers (ISIN: NL0015002SN0, CUSIP: N72482 156, WKN: A41HBE) will apply to the consolidated shares.
  • Fractional shares resulting from consolidation will be sold with proceeds deposited into shareholder accounts.
  • Capital repayments will be processed via the Depository Trust Company for US brokerage accounts & through Clearstream Banking AG for European accounts.
  • Shareholders holding shares directly at Equiniti will have holdings consolidated automatically with repayments sent to registered bank accounts.
  • The $500 million repurchase received virtually unanimous shareholder approval at the June 2025 Annual General Meeting.
  • QIAGEN is evaluating additional measures to increase returns in 2026 & beyond.
  • QIAGEN serves over 500,000 customers globally & employed approximately 5,700 people as of September 30, 2025.